Sun Pharmaceutical Industries Ltd Gets U.S. Nod for Generic Version of Pfizer Inc.'s Blood Pressure Drug

Bookmark and Share

Reuters -- India’s Sun Pharmaceutical Industries Ltd. said on Friday it had received approval from the U.S. Food and Drug Administration to launch generic version of Pfizer’s blood pressure drug Accupril.

MORE ON THIS TOPIC